Tumor Ablation Market (By Technology, Treatment Mode, Application, End-User, Regional Analysis), Company Profiles, Product Portfolio, Recent Developments, Key Trends and Market Dynamics - Global Forecast (2025 - 2032)

The global tumor ablation market is expected to reach US$ 4.15 billion by 2032, from US$ 1.67 billion in 2024. Tumor ablation is an image-guided, minimally invasive procedure used to destroy cancerous cells within the body. This technique uses various energy modalities, such as radiofrequency, microwave, cryotherapy, or laser, to target and eliminate tumors without the need for extensive surgery. Tumor ablation is recognized for its precision in targeting and destroying tumor cells without harming surrounding tissues, making it a preferred choice for treating small tumors in organs like the liver, lungs, and kidneys. The trend towards personalized medicine and precision oncology has boosted the demand for tumor ablation techniques, as they allow targeted treatment of tumors with greater precision. Additionally, the technological advancements to enhance accuracy, portability, and cost-effectiveness are likely to encourage market players to constantly improve and launch advanced tumor ablation devices. For instance, in December 2024, AngioDynamics, Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for the NanoKnife System for prostate tissue ablation.

Recent Developments

• In May 2025, Stryker announced that its OptaBlate basivertebral nerve ablation system (OptaBlate BVN) received 510(k) clearance from the U.S. Food and Drug Administration.
• In December 2024, AngioDynamics, Inc. announced that it had received U.S. Food and Drug Administration (FDA) 510(k) clearance for the NanoKnife System for prostate tissue ablation.
• In March 2024, Medtronic plc received U.S. Food and Drug Administration (FDA) 510(k) clearance for its OsteoCool 2.0 bone tumor ablation system for the treatment of painful bone metastases and benign bone tumors such as osteoid osteoma.
• In September 2024, Boston Scientific Corporation received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the FARAPULSE Pulsed Field Ablation (PFA) System.

By Technology: Global Tumor Ablation Market and Forecast - Key Takeaways

• Based on technology, the radiofrequency ablation segment led the market with the largest revenue share, owing to its advantages, such as specificity and efficiency in solid tumor ablation procedures in the liver, lung, and kidney.
• The microwave ablation technology segment is anticipated to witness the fastest growth over the forecast period. The energy of a microwave (MW) ablation device propagates an electromagnetic field, unlike an electric current in a radiofrequency ablation device. This improves the application of microwave ablation technology in tissue with low electrical conductance, such as bones and lungs.
• Cryoablation, which involves freezing the tumor cells, is gaining traction, particularly in treating cancer affecting sites like the liver, kidneys, and prostate.
• The high-intensity focused ultrasound (HIFU) was responsible for a low double-digit share of the overall tumor ablation market in 2024. High-intensity focused ultrasound therapy (HIFU) is an emerging modality that utilizes ultrasound waves.
• The irreversible electroporation (IRE) ablation is a novel, image-guided, minimally invasive outpatient procedure that aims to destroy cancerous cells by applying pulses of electrical energy through thin, needle-like electrodes placed in the targeted tissue.

By Treatment Mode: Global Tumor Ablation Market and Forecast - Key Takeaways

• Based on treatment mode, the percutaneous ablation segment dominated the global tumor ablation market as these procedures offer faster recovery, minimal scarring, and increased safety.
• Surgical ablation remains a conventional and highly effective approach for treating various types of tumors.
• The laparoscopic ablation segment is expected to register the fastest growth over the forecast period, owing to its ability to provide direct visualization of tumors, enabling precise treatment in complex cases.

By Application: Global Tumor Ablation Market and Forecast - Key Takeaways

• The liver cancer application segment dominated the global tumor ablation market with over 21% share in 2024, owing to the high prevalence of liver cancer cases worldwide and the surge in preference for minimally invasive treatment options.
• Kidney cancer accounted for a substantial share of the global tumor ablation market in 2024, backed by the increasing prevalence of kidney cancer globally and the growing adoption of minimally invasive treatments for renal tumors.
• Prostate cancer and bone cancer are competing to grab the maximum share of the global tumor ablation market.

By End-User: Global Tumor Ablation Market and Forecast - Key Takeaways

• Hospitals represent the largest end-user segment of the tumor ablation market, due to their comprehensive healthcare services and accessibility to a wide patient demographic.
• The oncology centers accounted for a significant share of the overall tumor ablation market in 2024. These specialized centers focus exclusively on cancer care and offer a wide range of services. These centers often have cutting-edge technologies and highly skilled specialists, which makes them attractive for patients seeking specialized care.

By Region: Global Tumor Ablation Market and Forecast - Key Takeaways

• North America dominates the global tumor ablation market, driven by several factors including high healthcare expenditure, advanced medical technologies, and a robust healthcare infrastructure.
• Europe represents the second largest market for tumor ablation, owing to the growing aging population, rising prevalence of cancer, and government measures to encourage ablation therapy treatment of cancer treatment.
• Asia Pacific is anticipated to grow at the fastest rate over the forecast period due to the presence of untapped opportunities in the emerging economies such as China and India.
• South America &the  Middle East, and Africa are competing to grab the maximum share of the global tumor ablation market.

The report provides a comprehensive assessment of the fast-evolving, high-growth Global Tumor Ablation Market.

This 215-page report with 110 Figures and 10 Tables has been analyzed from 9 viewpoints:

1. Global Tumor Ablation Market and Forecast (2018 - 2032)
2. Global Tumor Ablation Market Share and Forecast (2018 - 2032)
3. By Technology - Global Tumor Ablation Market and Forecast (2018 - 2032)
4. By Treatment Mode - Global Tumor Ablation Market and Forecast (2018 - 2032)
5. By Application - Global Tumor Ablation Market and Forecast (2018 - 2032)
6. By End-User - Global Tumor Ablation Market and Forecast (2018 - 2032)
7. By Region - Tumor Ablation Market and Forecast (2018 - 2032)
8. Global Tumor Ablation Market - Company Profiles (Overview, Revenue, Product Portfolio, Recent Developments)
9. Global Tumor Ablation Market Dynamics - Key Trends, Recent Developments, Growth Drivers & Challenges

By Technology - Global Tumor Ablation Market and Forecast

• Radiofrequency Ablation
• Microwave Ablation
• Cryoablation
• HIFU
• Irreversible Electroporation Ablation
• Others

By Treatment Mode - Global Tumor Ablation Market and Forecast

• Percutaneous Ablation
• Surgical Ablation
• Laparoscopic Ablation

By Application - Global Tumor Ablation Market and Forecast

• Liver Cancer
• Kidney Cancer
• Lung Cancer
• Breast Cancer
• Prostate Cancer
• Bone Cancer
• Other Cancers

By End-User - Global Tumor Ablation Market and Forecast

• Hospitals
• Oncology Centers
• Others

By Region - Global Tumor Ablation Market and Forecast

1. North America

• United States
• Canada
• Mexico

2. Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Denmark
• Norway
• Sweden
• Belgium
• Netherlands
• Switzerland
• Rest of Europe

3. Asia Pacific

• Japan
• China
• India
• South Korea
• Thailand
• Australia
• Rest of Asia Pacific

4. South America

• Brazil
• Argentina
• Rest of South America

5. Middle East & Africa

• Saudi Arabia
• UAE
• Kuwait
• South Africa
• Rest of Middle East and Africa

Global Tumor Ablation Market - Company Profiles (Overview, Revenue, Product Portfolio, Recent Developments)

1. Boston Scientific Corporation
2. Medtronic plc
3. Olympus Corporation
4. Stryker Corporation
5. Merit Medical Systems
6. HealthTronics, Inc.
7. Insightec
8. AngioDynamics
9. Integra LifeSciences
10. NeuWave Medical, Inc. (Johnson & Johnson MedTech)
11. EDAP TMS S.A.
12. Erbe Elektromedizin GmbH
13. IceCure Medical Ltd
14. Bioventus Inc. (Misonix Inc.)
15. Varian Medical Systems
16. Mermaid Medical
17. Canyon Medical Inc.
18. Chongqing Haifu Medical Technology Co., Ltd.

Data Sources

The publisher employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from the Proprietary Information Database, Primary and Secondary Research Methodologies, and in-house analysis by a dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interviews, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies' Annual Reports, Government Agencies, Libraries, and Local Councils, and a large number of Paid Databases.